chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10 minutes after administering .5ml AFLURIA Influenza vaccine pt reported tingling to leg that spread to calves was given 50 mg BENADRYL in clinic. Phone call to patient approximately 1 hour later when at home. Reported tingling to get resolved but had a slight headache.
SEVERE FEVER, FATIGUE, CHILLS 24 HOURS AFTER VACCINE....LASTED 7 DAYS.
Woke up with pain in Left Hip.  Would cry out in pain if leg was touched or moved.  Would not stand on leg.  Cried even when carried.  Took to Doctor, and determined leg was not broken. Gave ibuprofen. Stiff leg and very sore, but started to walk, and then limp.  Took 3 days for pain to go away, and 1 more day to completely stop limping.  Then, it started again 3/17/2010 (8 days later).  Same symptoms, and again took 4 days to get completely well.  Doctor encouraged us to get an MRI done to see what is wrong with the hip.  Waiting to see if symptoms come back again before doing this costly procedure ($1100).
syncope, fainting. patient mentioned he felt nervous when getting vaccine and felt better after taking xanax prescription
Vaccine administered, as per protocol notified parent of expired vaccine. As per parent not reaction noted.
About two and half weeks after the first shot, I experienced phantom smoke smells for about a day and half.  (This was the same smell that I experienced from March to June 2021 after having a January 2021 Covid infection.  The smell is a burnt grease smell.)  Then, about the same time after the second shot (lot 033H21A), I experienced the same phantom smoke smells again.  However, this has continued off and on and is still continuing as of January 2, 2021.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 14-DEC-2018 the patient was vaccinated with a pediatric dose of VAQTA lot # N023953, expiration date: 05-NOV-2018, intramuscular, for prophylaxis (dose, frequency were not reported), instead of an adult dosage. Additionally the nurse reported that the VAQTA was discovered to be expired. No adverse event was reported.
Localized left deltoid reaction of redness/ swelling measuring 10cmx10cm. Patient complained of itching/ pain about 24 hours after injection at which time reaction was noted. No further symptom reported.
Principal Problem: COVID-19      Assessment & Plan Note:     Patient is a 91 year old male with AD, HTN who presents for COVID+  Patient's son tested positive 9/16, isolation began since then Patient tested positive 9/20 Recently hospitalized and discharged 9/5 (hospitalized for constipation/ileus) Patient vaccinated Pfizer (1/2021) No oxygen requirements, no role for decadron or remdesivir at this time Unknown if any relationship of mental status changes to COVID diagnosis, but otherwise has no symptoms related to COVID and does not meet criteria for monoclonal antibody therapy at the present time    ? Hyponatremia
Patient received first dose of COVID19 Pfizer vaccine and stood up  walked to a waiting room chair then within a minute or two experienced syncope for around a minute. Patient came 2 but was pale and still did not feel well. EMS was called and came to the scene checked blood pressure and released patient to care of the parent.
Patient is not having any adverse events and dose not need treatment. Gave 2nd dose 20 days after the 1st dose
heat, cluster of little bity bumps on the backside of my back, lower part of the back; A spontaneous report was received from a consumer, concerning a female patient (age unspecified) who was administered Moderna's COVID-19 vaccine (mRNA-1273) and experienced heat, cluster of little bity bumps on the backside of my back, lower part of the back.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 23-DEC-2020, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) unknown route, in an unknown arm for prophylaxis of COVID-19 infection.   Reporter stated that she is calling concerning Moderna Covid-19 vaccine that she had received on 23-DEC-2020. Patient reported having  "heat, clusters of little bity bumps on the  lower part of the back" "looks a little rash, thought it was heat bumps at first, but not sure". Patient stated she did not have this before the vaccine.   Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not provided.   Outcome of the event, heat, cluster of little bity bumps on the backside of my back, lower part of the back, was considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Within 2 minutes of injection in right shoulder I experienced pruritus and erythema.  Within 5 minutes the erythema covered the upper half of my arm and extended over my shoulder. Swelling of the injection sight and ~2 cm surrounding the site. Entire deltiod area became hot to the touch. Erythema, pruritus, induration, and hot skin persisted for 5 days.
Information has been received from a office worker concerning her 12 year old female child who on an unspecified date, was vaccinated with the second dose of VARIVAX (Merck) (lot number not reported). The office worker stated that "2 weeks previous to 3/14/2011" (on approximately 28-FEB-2011), her child contracted shingles after receiving the second dose of VARIVAX (Merck). It was reported that the patient received prednisone (also reported as prednozone) and an anti viral for the treatment of the event. At the time of the report the patient was recovering. The patient sought unspecified medical attention. Additional information has been requested.
I had a sore arm after receiving the vaccine. A strange thing happen during receiving the vaccine, liquid ran down my arm.  I started not feeling well on 07/10 and I tested positive with a home for COVID-19. I followed-up with a PCR test that confirmed I was positive for COVID-19. I went to urgent care  for the PCR test and had a telehealth visit with my primary care doctor. They wrote a prescription for Paxlovid.
Moderate to severe local reaction occuring 4 days after vaccine administration.  Extending to elbow-estimate 10x 12 cm size.
Approx. 1 wk. after #2 HEP-A, pt developed raised reddish papules across his groin and sternum, lasting approx. 3 weeks. He was also stung by an insect during this time.
pt recv vax 2JAN96 & pt devel a chicken pox rash of fix pox only;pt recovered;
swollen interphalangeal joints (both hands) with pain; I developed swollen interphalangeal joints (both hands) with pain and resolvable "locking" of my middle fingers; This is a spontaneous report from a contactable Pharmacist (Patient). A 59-Year-old male patient reported for himself that he received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine; Solution for injection; Lot number: EL0140; Expiry date: Unknown) via an unknown route of administration in the left arm on 11Jan2021 at 12:30PM as a single dose for COVID-19 immunization. The patient did not have COVID-19 prior to vaccination. The patients past medical history included Diabetes (Type 2), Hypertension and Hypercholesterolemia. The patient did not have any known allergies. Concomitant medication were not reported. On 18Jan2021, at 07:00 AM seven days after receiving initial COVID-19 vaccine, Patient developed swollen interphalangeal joints (both hands) with pain and resolvable "locking" of my middle fingers. Nine days after second COVID-19 vaccine, the issue resolved. The patient did not receive any treatment. The clinical outcome of developed swollen interphalangeal joints (both hands) with pain and resolvable "locking" of my middle fingers were considered recovered.
A serious spontaneous report of myoclonic spasms of lower and upper extremities was received from a physician concerning herself, a 37-year-old female subsequent to FLUMIST.  The patient's past medical history includes attention-deficit hyperactivity disorder (ADHD), an auto-immune disorder not otherwise specified with hyperactive immune system, and she developed myoclonic jerks one week after receiving FLUMIST in 2006 (MEDI-0007588).  Concomitant medications include LISDEXAMFETAMINE since 25-SEP-2008 for ADHD.  The patient received FLUMIST intranasally on 23-Oct-2008 for prevention of flu.  Approximately five days after receiving FLUMIST, the patient experienced brief "tic-like" myoclonic jerks of the lower and upper extremities when relaxed.  The symptoms from this occurrence are less than the first occurrence in 2006.  She received an IM influenza injection in 2007 with no problems.  The patient stated that she is getting better as evidenced by initially twitching three to four twitches per day, but now she is twitching three to four times per week.  The patient stated that she does not plan to see a specialist. Required follow-up attempts have been performed, requested information unable to be obtained.
Very bad pain on the side of the head down my neck and arm across the back of my head my neck and across my shoulder for about 2 weeks.
pt recvd vax & 30 mins later presented to ER c/o tachycardia, dry mouth, h/a, lightheadedness, face feeling hot; PE revealed a nl temp, BP 220/114; skin was diaphoretic; labored resp, hypertens, near syncope;
This spontaneous report was received from a physician via company representative and refers to a adult patients of unknown age and gender, described in the article entitled "Shingles Vaccine May Pose Eye risk in some people".  There was no information about patient's pertinent medical histories, concomitant medications, drug reactions or allergies provided. On an unknown dates, the adult patients were vaccinated with ZOSTAVAX injection (lot#, expiration date, dose, anatomical location and route of administration were not reported). On an unknown dates, within 24 hours after vaccination, the patients experienced keratitis, which had been linked to autoimmune disorder or inflammation of the clear layer on the front of the eye. The events could cause serious complications or event permanent damage to vision, if was left untreated. The outcome of the events was unknown. The reporter considered the events to be probable related to ZOSTAVAX. However, the new study was not designed to prove that the vaccine caused that condition. This is one of several reported received from the same reporter. Additional information has been requested.
At the time of my first vaccine on 1/14/21 I was 9 weeks pregnant and on lovenox for DVT and progesterone for pregnancy maintenance. On 2/5/21 I miscarried the baby and ended up hemmoraging thus requiring a blood transfusion. The fetus was sent to pathology and I was informed that at 12 weeks when I miscarried that the baby had termed at 9 weeks which was the time of my first vaccine injection.
swelling; itching/ large red circle associated with pain and itching; pain/ large red circle associated with pain and itching; large red circle that progressively got bigger/ the mark is there faded; This case was reported by a physician and described the occurrence of swelling in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included drug allergy (allergies to other medications like prednisone pack, valtrex, antivirals).   On 6th November 2020, the patient received the 1st dose of Shingrix. On 7th November 2020, 1 days after receiving Shingrix, the patient experienced swelling, localized itching, pain localized and localized erythema. On 23rd November 2020, the outcome of the swelling, localized itching, pain localized and localized erythema were recovered/resolved.   It was unknown if the reporter considered the swelling, localized itching, pain localized and localized erythema to be related to Shingrix.  Additional details were provided as follows: The patient had allergies to other medications like prednisone pack, Valtrex, antivirals. The reporter did not know the route of administration or the lot and expiry details of Shingrix as the vaccine was administered at a local pharmacy. The patient experienced some pain, itching and swelling. The reporter upon escalation stated patient described it that it started the next day as large red circle that progressively got bigger a few days later and was associated with pain and itching. It was still there, the mark was there faded. The pain, itching and swelling had resolved. None of the other symptoms had persisted. The symptoms lasted a day before reporting for about 17 days. The reporter consented to follow up. This case has been linked with US2020AMR234423 reported for the same patient by same reporter. There was discrepancy in the reported duration for the events. The reporter stated the event stated the next day until a day before reporting that was 16 days, however he stated that the events lasted for about 17 days.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR234423:Same patient, Valtrex case
Pt's son called and stated she was vomiting, having muscle weakness, feeling lightheaded, and was sweating. (She passed out but the son told me she almost fainted, was not aware of the fall this morning). You stated she did pass out on the brick steps. She is feeling much better now (I talked to her at 5:51 pm on 10/11/17). She doesn't feel like she needs to see the doctor. She did fall on her steps and feels like she might have bruised her ribs. I did tell her to take it easy and to see the doctor if continuing to have any other issues. She did reiterate that she is feeling fine now.
BOOSTRIX-Tdap administered 4-7-14. Pt. developed cellulitis after injection.
mom noted red marks on forehead 4 hrs after inject & inject site swelling, raised bumps ?hives, swelling head to neck & redness at chest & neck, eyes puffy, feet swollen upper rt looked like bee sting around 8pm. m.d. seen 8 days after shot
0.25ml Fluvirin given.  Rec for >4yrs.  Box marked but not on actual vial.  Pt had no reaction.
Tested positive for Covid; Cough; Extremely weak; Tired; Low fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for Covid), COUGH (Cough), ASTHENIA (Extremely weak), FATIGUE (Tired) and PYREXIA (Low fever) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced COUGH (Cough), ASTHENIA (Extremely weak), FATIGUE (Tired) and PYREXIA (Low fever). On 05-Feb-2021, the patient experienced COVID-19 (Tested positive for Covid). At the time of the report, COVID-19 (Tested positive for Covid), COUGH (Cough), ASTHENIA (Extremely weak), FATIGUE (Tired) and PYREXIA (Low fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, SARS-CoV-2 test: unknown (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were  provided by the reporter. Treatment included Infusion of bam was noted.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Contains no new information.
Pt had 4 vaccines for overseas travel at about 11:00 on 8/31/01 (Typhoid VI, Hep-A, IG-IM and Pneumococcal PS). She received Hep-A, IM and Pneumococcal PS, SC in her left arm. Pt developed a temperature up to 101.8F by 00:01 on 9/1/01 with 50 cent-sized erythema and induration and body aches. Temperature resolved by later on 9/1/01 with Tylenol use. Still had erythema over 1" on 9/4/01, but by location, reaction likely due to pneumococcal vaccine.
On 12/19/2022 I got a sore throat and it turned into a cough and a headache, the next day I tested positive for COVID-19. I had tested negative on 12/18/2022 my wife having tested positive that day. I started on PAXLOVID on 12/20/2022 and took it for five days my last dose being on Christmas morning. On 12/21/2022-12/22/2022 my throat was very sore overnight. The day after Christmas and two days later I tested negative for COVID-19 and on 01/09/2023 I was congested and began coughing overnight with post nasal drip but tested negative for COVID-19.
A report was received from a health care professional on 09Dec02 concerning a 47 year old male vaccinee who experienced pain and weakness on the anterior, middle and posterior left deltoid 10 to 14 days after receiving Fluvirin in the week beginning 04Nov02. Ten to fourteen days after receiving 0.5ml Fluvirin IM on the 04Nov02 the vaccinee experienced pain and weakness on the anterior, middle and posterior left deltoid. At the time of reporting it was reported that 80% of the pain had resolved and the weakness had resolved completely. There was insufficient information to determine the reporters causality assessment.
Soreness at injection site; Some fatigue (3rd dose); 3rd dose; This is a spontaneous report received from a contactable reporter (Other HCP). The reporter is the patient.  A 22 year-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19), administered in arm left, administration date 12Dec2021 09:45 (Lot number: FD7218) at the age of 22 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "covid prior vaccination" (unspecified if ongoing), notes: Covid prior vaccination: Yes; "Appendectomy", start date: 2004, stop date: 2004; "Oral herpes" (unspecified if ongoing); "Seasonal allergies" (unspecified if ongoing). Concomitant medication(s) included: MG [MAGNESIUM]; ZINC; ASHWAGANDHA ROOT; VITAMIN C [ASCORBIC ACID]. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0173, Location of injection: Arm Left, Vaccine Administration Time: 05:00 PM, Soreness at injection site (left arm) (all 3 doses): recovered from first two, injections), administration date: 03May2021, when the patient was 21 years old, for COVID-19 immunization, reaction(s): "Soreness at injection site"; Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0158, Location of injection: Arm Left, Vaccine Administration Time: 05:00 PM, Soreness at injection site (left arm) (all 3 doses): recovered from first two, injections), administration date: 12Apr2021, when the patient was 21 years old, for Covid-19 immunization, reaction(s): "Soreness at injection site". The following information was reported: IMMUNISATION (non-serious) with onset 12Dec2021 09:45, outcome "unknown", described as "3rd dose"; VACCINATION SITE PAIN (non-serious) with onset 12Dec2021 16:00, outcome "unknown", described as "Soreness at injection site"; FATIGUE (non-serious) with onset 12Dec2021 16:00, outcome "unknown", described as "Some fatigue (3rd dose)". Therapeutic measures were not taken as a result of vaccination site pain, fatigue. Additional information: patient was not tested for COVID after the vaccination,  None of the known allergies. patient has not received other vaccine in four weeks. other medications in two weeks also include Multi-vitamin.  No follow-up attempts are possible. No further information is expected.  Follow-Up (21Dec2021):Follow-up attempts are completed. No further information is expected
Patient received extra primary dose of Pfizer Lot#: FT1551 instead of Pfizer Bivalent booster. Parents notified and informed child qualifies for bivalent dose if desired in 2-3 months from today. All questions and concerns addressed.
Vaccine was given on 10/19/23 around 12;30 pm. shortley after pt began having numbness to the left side of his face, some numbness in left arm,  left eye swelling. He called the pharmacy and then came to our office. He arrived at our office around 3pm and we assessed him and gave him a dose of IM steroids.
Patient was given the FLUZONE high dose instead of the FLUARIX regular dose by mistake. I was not even aware of the mistake until billing pointed out the error and insurance would not cover the cost. Patient is aged 52 instead of age 65 as indicated. Patient experienced no reported adverse reaction or side effect.
Narrative:  PATIENT PRESENTED TO E.D. WITH ACUTE ABDOMINAL PAIN, DIAGNOSED WITH SMALL BOWEL OBSTRUCTION. TESTED POSITIVE FOR COVID-19 INFECTION, HOWEVER PATIENT WAS COMPLETELY ASYMPTOMATIC OTHERWISE. PATIENT FULLY VACCINATED WITH COVID-19 VACCINES GIVEN ON 2/12/21 AND 3/5/21. Patient treated with NG tube suction, SBO resolved without surgical intervention.
it made me turned flushed, really almost purple/ My face was red, arms were red, my neck was red; Sweating; The initial case was missing the following minimum criteria: adverse event nos. Upon receipt of follow-up information on (27Dec2020), this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer (patient herself). A 53-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EH9899, expiry date not reported), via an unspecified route of administration on 21Dec2020 at single dose for COVID-19 immunisation. Medical history included blood pressure high. Concomitant medications included metoprolol, hydrochlorothiazide, and lisinopril; all from unspecified dates for blood pressure high. The patient verbalized, "I had the vaccine on last Monday be 21st. I had an issue and ended up in the ER. It made me turned flushed, really almost purple, no anaphylactic nothing, just sweating, my face was red, arms were red, my neck was red but that is it. They gave me Pepcid and Benadryl in ER and watched me in the ER for about 40 minutes. I work at the hospital and I got it from them. I was fine the rest of the week, Thursday, my son came by to pick up a couple of holiday gifts only saw him for 5 minutes. He has now tested positive for COVID. We had masks on. I hugged him on his way out. He took the gifts and left. He is at home now. He got tested yesterday positive for COVID. My question is am I still at risk of getting it from that meeting after I only had one shot?" On an unspecified date, the patient underwent lab tests and procedures which included blood pressure measurement: 133/85 and body temperature: 97.9. Therapeutic measures were taken as a result of the events that included Pepcid and Benadryl. Clinical outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Extremely elevated heart rate if 160 while sitting down 25 minutes after receiving vaccine; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 24-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 19Apr2021 11:30 (Batch/Lot Number: EW0151) as dose 1, single (age at vaccination 24-year-old) for covid-19 immunisation. Medical history included known allergies: Nuts, oysters from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. Patient received other medications within 2 weeks of vaccination includes birth control. The patient experienced extremely elevated heart rate if 160 while sitting down 25 minutes after receiving vaccine on 19Apr2021 11:45. Therapeutic measures were taken as a result of event includes vitals taken and extended watch time at clinic. The outcome for event was recovering.   No follow-up attempts are possible. No further information is expected